BRASKEM PFD ADR/2 O.N. (BRD) - Total Liabilities
Based on the latest financial reports, BRASKEM PFD ADR/2 O.N. (BRD) has total liabilities worth €98.38 Billion EUR (≈ $115.02 Billion USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore BRASKEM PFD ADR/2 O.N. cash conversion from operations to assess how effectively this company generates cash.
BRASKEM PFD ADR/2 O.N. - Total Liabilities Trend (2021–2025)
This chart illustrates how BRASKEM PFD ADR/2 O.N.'s total liabilities have evolved over time, based on quarterly financial data. Check asset resilience ratio of BRASKEM PFD ADR/2 O.N. to evaluate the company's liquid asset resilience ratio.
BRASKEM PFD ADR/2 O.N. Competitors by Total Liabilities
The table below lists competitors of BRASKEM PFD ADR/2 O.N. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Citra Marga Nusaphala Persada
JK:CMNP
|
Indonesia | Rp8.89 Trillion |
|
Qualipoly Chemical Corp
TW:4722
|
Taiwan | NT$3.18 Billion |
|
PNC Infratech Limited
NSE:PNCINFRA
|
India | Rs71.55 Billion |
|
HIVE Digital Technologies Ltd
NASDAQ:HIVE
|
USA | $68.37 Million |
|
Shenzhen Soling Industrial Co Ltd
SHE:002766
|
China | CN¥236.44 Million |
|
Guangzhou Jiacheng
SHG:603535
|
China | CN¥2.21 Billion |
|
Sabre Corpo
NASDAQ:SABR
|
USA | $5.53 Billion |
|
Vibhavadi Medical Center Public Company Limited
BK:VIBHA
|
Thailand | ฿11.86 Billion |
Liability Composition Analysis (2021–2025)
This chart breaks down BRASKEM PFD ADR/2 O.N.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see BRASKEM PFD ADR/2 O.N. market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.76 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -6.09 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.20 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how BRASKEM PFD ADR/2 O.N.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for BRASKEM PFD ADR/2 O.N. (2021–2025)
The table below shows the annual total liabilities of BRASKEM PFD ADR/2 O.N. from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €98.38 Billion ≈ $115.02 Billion |
-7.06% |
| 2024-12-31 | €105.85 Billion ≈ $123.75 Billion |
+19.66% |
| 2023-12-31 | €88.46 Billion ≈ $103.42 Billion |
+7.96% |
| 2022-12-31 | €81.94 Billion ≈ $95.80 Billion |
-5.12% |
| 2021-12-31 | €86.36 Billion ≈ $100.96 Billion |
-- |
About BRASKEM PFD ADR/2 O.N.
Braskem S.A., together with its subsidiaries, engages in the manufacture, sale, import, and export of chemicals, petrochemicals, and fuels in Brazil. It produces and sells polyethylene (PE), polypropylene, tertiary-butyl ethyl ether, gasoline, benzene, toluene, xylene, ethylene, propylene, polyvinyl chloride, caustic soda, butadiene, cumene, naphtha, solvents, and condensate; thermoplastic resins… Read more